Commentary: Sorafenib - The end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning? Journal Article
| Author: | Abou-Alfa, G. K. |
| Article Title: | Commentary: Sorafenib - The end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning? |
| Keywords: | treatment response; sorafenib; placebo; area under the curve; chemoembolization; drug efficacy; drug safety; hepatic encephalopathy; liver cell carcinoma; liver cirrhosis; antineoplastic agents; benzenesulfonates; carcinoma, hepatocellular; liver neoplasms; pyridines; drug approval; liver dysfunction; note; united states; united states food and drug administration |
| Journal Title: | The Oncologist |
| Volume: | 14 |
| Issue: | 1 |
| ISSN: | 1083-7159 |
| Publisher: | Oxford University Press |
| Date Published: | 2009-01-14 |
| Start Page: | 92 |
| End Page: | 94 |
| Language: | English |
| DOI: | 10.1634/theoncologist.2008-0294 |
| PUBMED: | 19144679 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "CODEN: OCOLF" - "Source: Scopus" |
